Innovation Management Valuation Multiples

Explore private market Innovation Management valuation multiples with benchmarks structured by stage and region. Updated quarterly.

Coverage
EV/Sales; EV/EBITDA
Valuation Multiples
Private Market
Benchmarks
Stage & Region
Adjustment
Quarterly
Updated
Sector Profile

Innovation Management

Innovation-management companies help organisations run R&D, ideation, and venturing. Private-market valuations reflect recurring revenue, retention, and the stickiness of innovation workflows.

The category spans innovation software, R&D management, and corporate-venturing tools. DealMatrix tracks valuation dynamics across 7 funding stages and all major global regions, updated every quarter.

Key Drivers
→
Recurring Revenue & Retention
Mission-critical software with high retention commands premiums.
→
Workflow Stickiness
Embedding in R&D and innovation workflows creates switching costs.
→
Measurable ROI
Clear innovation outcomes make the spend defensible.
→
Data & Integrations
Proprietary data and integrations deepen the moat.

Sector

Innovation Management

Professional Services

Sector tracked since

2000

25+ years of data

EV/SALES & EV/EBITDA ACROSS

6 Regions, 7 Stages

Modelled independently via proprietary econometric approach

UPDATE FREQUENCY

Quarterly

Data updates & model improvement

Benchmark

Innovation Management Valuation Multiples by Stage

As of 30 September 2025, calculated as on the DealMatrix platform

Innovation Management EV/Sales by funding stage · All regions
EV/Sales
5.6×
8.4×
10.5×
7.0×
4.9×
3.5×
2.8×
Pre-SeedSeedSeries ASeries BSeries CSeries DSeries E
EV/EBITDA
n/mn/mn/mn/m24.7×17.6×14.1×

EV/EBITDA is shown from Series C onwards.

How we derive these multiples

DealMatrix multiples are derived from institutional-grade public-market index data covering ~150 GICS sub-industries across 6 regions, with quarterly history back to 2000, and adjusted for region and funding stage in a six-step model that follows the IPEV Guidelines 2025. Published benchmarks are one year old and illustrative; because IPEV 2025 prohibits static multiples for reporting periods from 1 April 2026, current quarterly data for valuation work is available on the platform.

Read the full methodology →

Your region, your industry blend, the current quarter

These figures are as of 30 September 2025, one year behind the platform. On the platform you combine up to four industries and get the current quarter.

Try for free →
Methodology

The Venionaire DealMatrix Multiples Model

DealMatrix multiples are proprietary private-market benchmarks, derived through a six-step model that translates public capital-market index comparables into private-market segments and funding stages, adjusted for macroeconomic conditions.

The model produces three components: The reported public multiple, the model-predicted multiple, and the lower bound predicted multiple averaged into the DealMatrix Composite, then adjusted for region and funding stage. The methodology follows the IPEV Guidelines 2025.

Model Architecture
01
Data Acquisition
200 Public Indices
02
Statistical Cleaning
Outliers & Gaps
03
Econometric Modelling
Macro & Averaging
04
Regional Adjustment
6 Regions
05
Industry Weighting
150 Categories
06
Stage Adjustment
Pre-Seed → Series E
Final DealMatrix Multiple
EV/Sales and EV/EBITDA by sector, region and stage
Following IPEV Guidelines 2025, updated each quarter
Deals Monitor
Latest Innovation Management Deals
Related Industries

Similar industries to explore

Valuation benchmarks differ across industries as business models, growth rates and margins vary. Explore the sectors most related to Innovation Management to see how their EV/Sales and EV/EBITDA multiples compare.

Innovation Management Valuation Multiples — FAQ

What is the average valuation multiple for Innovation Management companies?

As of 30 September 2025, across all regions, venture-backed Innovation Management companies were valued at about 2.8× to 10.5× EV/Sales, depending on the funding stage: 10.5× at Series A, 4.9× at Series C and 2.8× at Series E. EV/EBITDA was about 24.7× at Series C and 14.1× at Series E. Region-specific and current-quarter figures are available in DealMatrix.

How does the funding stage change Innovation Management multiples?

Multiples rise from Pre-Seed to a peak at Series A (10.5× EV/Sales for Innovation Management): growth is still very high while the risk investors price in has fallen. From Series B on, growth slows faster than risk falls, and multiples come down towards the level of listed companies by Series D and E. EV/EBITDA is shown from Series C onwards.

What is the difference between EV/Sales and EV/EBITDA for Innovation Management?

EV/Sales (enterprise value ÷ revenue) is used for high-growth Innovation Management companies that are not yet profitable, while EV/EBITDA (enterprise value ÷ operating profit) applies to mature, profitable ones. Early-stage companies are usually benchmarked on EV/Sales.

How are Innovation Management valuation multiples calculated?

Each Innovation Management multiple is a weighted blend of public-market index comparables, cleaned for outliers and gaps, then adjusted for macroeconomic conditions, region, and funding stage through a six-step model that follows the IPEV Guidelines 2025.

Do Innovation Management valuation multiples vary by region?

Yes. North America serves as the reference market and typically carries the highest multiples, while emerging markets trade at a structural discount. Region-specific figures are available in the DealMatrix platform.

How current is this Innovation Management data and how often is it updated?

The benchmark shown is an illustrative annual figure as of 30 September 2025. The underlying model is updated every quarter. Because the IPEV Guidelines 2025 prohibit static multiples for reporting periods from 1 April 2026, current quarterly data for valuations is available in the DealMatrix platform.

COMPANY VALUATION

Start using data-driven private equity/venture capital multiples.